Welcome to APOLLO

APOLLO is a national observational study. The purpose of this study is to test kidney donors and kidney transplant recipients for variants (or forms) of the apolipoprotein L1 gene (called APOL1) to determine whether they impact outcomes. APOLLO will follow individuals who receive a kidney from an eligible (living or deceased) kidney donor. In addition, APOLLO will follow individuals who donate a kidney to assess the impact of the APOL1 gene. This study is being done to improve outcomes after kidney donation and kidney transplantation.

APOLLO is coordinated by the Wake Forest School of Medicine and has 13 Network Hubs that will work with all of the transplant programs in the United States, including Puerto Rico.

If there have been any changes to your contact details since your enrollment in the study (change of address, email or phone number), we kindly request that you reach out to your recruiting site and provide your updated information. This ensures seamless communication and timely delivery of your genotyping results, as well as any future updates regarding the APOLLO study.

More information »

Best Practices in Next of Kin Research Authorization After Consent for Organ Donation

APOLLO Statement on Racial Injustice

Potential Participants and Community »

Publications and Presentations

APOLLO Patient & Community Website

How to Get Started Using X Guide (X 101)

2023 Fall Participant Newsletter »  (Spanish version)

2023 Spring Participant Newsletter »  (Spanish version)

DYMO Printer

Facebook YouTube Twitter